Elliott Mark Boulding Net Worth & Insider Trades
Elliott Mark Boulding - EXEC. VP AND CLO, Ptc Therapeutics, Inc
What is Elliott Mark Boulding's Net Worth?
The current estimated net worth of Ptc Therapeutics, Inc's EXEC. VP AND CLO, Elliott Mark Boulding, is estimated to be about $21.67M . Elliott Mark Boulding owns about 75,378 units of Ptc Therapeutics, Inc common stock. In the last 9 years at Ptc Therapeutics, Inc, Elliott Mark Boulding has sold an estimated value of $20.81M worth.
What is Elliott Mark Boulding's Past Insider Trading?
Elliott Mark Boulding's largest purchase order was 181,667 units , worth over $3.4M on July 2, 2019. Elliott Mark Boulding's largest sale order was 181,667 units , worth over $8.18M on July 2, 2019. In total, Elliott Mark Boulding has made about 30 transactions over 9 years of their time at Ptc Therapeutics, Inc. Elliott Mark Boulding usually trades in January, with the busiest year in 2022. The most recent transaction was a sale order of 61,923 units , worth over $3.18M on April 19, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Elliott Mark Boulding
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Elliott Mark Boulding's' Mailing Address?
- Mailing address is C/o Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 NJ
What are Ptc Therapeutics, Inc's Past Insider Trades?
Ptc Therapeutics, Inc's most recent insider trade came on September 8, 2023 by Alethia Young who sold 11,666 units worth $464.97K . In the last 10 years, insiders at Ptc Therapeutics, Inc have sold an estimated value of $171.3M and bought an estimated value of $106.06M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER, Gregory Neil Almstead, CHIEF TECHNICAL OPS OFFICER, and Elliott Mark Boulding, EXEC. VP AND CLO .
PTC THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||